Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.

MLA

Pifarré, Paula, et al. “Phosphodiesterase 5 Inhibition at Disease Onset Prevents Experimental Autoimmune Encephalomyelitis Progression through Immunoregulatory and Neuroprotective Actions.” Experimental Neurology, vol. 251, Jan. 2014, pp. 58–71. EBSCOhost, https://doi.org/10.1016/j.expneurol.2013.10.021.

APA

Pifarré, P., Gutierrez-Mecinas, M., Prado, J., Usero, L., Roura-Mir, C., Giralt, M., Hidalgo, J., & García, A. (2014). Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions. Experimental Neurology, 251, 58–71. https://doi.org/10.1016/j.expneurol.2013.10.021

Chicago

Pifarré, Paula, María Gutierrez-Mecinas, Judith Prado, Lorena Usero, Carme Roura-Mir, Mercedes Giralt, Juan Hidalgo, and Agustina García. 2014. “Phosphodiesterase 5 Inhibition at Disease Onset Prevents Experimental Autoimmune Encephalomyelitis Progression through Immunoregulatory and Neuroprotective Actions.” Experimental Neurology 251 (January): 58–71. doi:10.1016/j.expneurol.2013.10.021.